If you liked this article you might like

Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
XBiotech Colon Cancer Drug Data Deemed Unreliable by European Group
XBiotech Cancer Drug Survival Claim Falls Apart Under Scrutiny
7 Stocks Spiking on Big Volume